Hello Jenni Nordborg!

Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...

Business Sweden’s new team is rolling out the blue-yellow carpet

According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...

Novo Nordisk buys drug candidate in billion dollar deal

The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...

Jeeves ingår partnerskap med Frends

Vi på Jeeves är glada att kunna meddela att vi från och med nu kommer samarbeta kring integrationer med Frends. Vi tror att samverkan är vägen till det starkast...

Precision medicine centre: “Extensive activity on several fronts”

Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech ...

Beslut idag: 17 innovationsprojekt får finansiering

I tuff konkurrens har 17 nya innovationsprojekt inom life science valts ut och får finansiering via Medtech4health och Swelife.

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Column: ”We need to exploit the benefits of the regulations“

You don’t need to search long on the Internet to find lists of the most innovative countries with Sweden ranking at the top. Sweden generally offers good condit...

Lucy Robertshaw: Are we in the perfect storm?

“Is there a perfect storm on the horizon again as elective surgeries were cancelled due to patients being admitted with Covid-19? We now have a long backlog of ...

Medicinpriset till forskare bakom mRNA och första covidvaccinen

Årets Nobelpris i fysiologi eller medicin går till förhandstippade Katalin Karikó och Drew Weissman från University of Pennsylvania.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network ...

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...

EU sätter stopp för Illuminas köp av Grail

Under tisdagen meddelade EU-kommissionen att de stoppar det amerikanska genteknikbolaget Illuminas redan genomförda köp av diagnostikbolaget Grail.

Biotechprojekt får miljonstöd

Stamcellsterapi av covid-19-relaterad ARDS och mini-hjärnor för AI-baserad läkemedels-screening. Det är två av projekten som får stöd när Swelife och Medtech4he...

Anna Törner: The minute between life and death

“I have never told anyone about this day that happened more than 20 years ago. But I sometimes reflect on what happened, on what might have happened. When I try...

BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”

For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

New diagnostic test soon ready for the market

Faster development of reliable sample handling

to integrate into the customer's platform – with standard components from Festo, a PerkinElmer® JANUS G3 workstation and a modified rotary gripper module. This ...

Studie: Blodprov för att mäta hjärnpåverkan efter neurokirurgi

I framtiden tror forskare vid Göteborgs universitet att ett blodprov skulle kunna vara ett komplement till magnetkamera för att undersöka skador i samband med k...

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...